Valuation: Femasys Inc.

Market Cap 20.77M 18.23M 17.21M 15.69M 29.36M 1.99B 29.57M 206M 79.78M 1.02B 77.98M 76.3M 3.27B P/E 2026 *
-0.95x
P/E 2027 * -1.42x
Enterprise Value 20.77M 18.23M 17.21M 15.69M 29.36M 1.99B 29.57M 206M 79.78M 1.02B 77.98M 76.3M 3.27B EV / Sales 2026 *
9.96x
EV / Sales 2027 * 2.32x
Free-Float
96.01%
Yield 2026 *
-
Yield 2027 * -
1 day+2.06%
1 week-4.25%
Current month-27.70%
1 month-15.07%
3 months-34.74%
6 months-75.11%
Current year-78.48%
1 week 2.42
Extreme 2.42
2.69
1 month 2.42
Extreme 2.42
3.44
Current year 2.02
Extreme 2.0223
14.51
1 year 2.02
Extreme 2.0223
22.2
3 years 2.02
Extreme 2.0223
95
5 years 2.02
Extreme 2.0223
162
10 years 2.02
Extreme 2.0223
275
Manager TitleAgeSince
Chief Executive Officer 58 2003-12-31
Director of Finance/CFO 58 2022-02-27
Chief Operating Officer 52 2026-03-29
Director TitleAgeSince
Chairman 58 2003-12-31
Chairman 74 2022-07-05
Director/Board Member 75 2005-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/7/26 Buy

Chief Technology Officer

9,375 0.1166%
8/7/26 Buy

Chief Financial Officer

46,875 0.5832%
8/7/26 Buy

Founder

46,875 0.5832%
Change 5-day change 1-year change 3-year change Capi.($)
+2.06%-4.25%-65.54%-91.62% 20.77M
+0.22%-1.29%-24.16%+5.26% 175B
+0.97%-3.79%-5.92%+12.27% 113B
-0.95%-0.60%-0.03%+65.22% 58.57B
+2.56%+1.59%-0.42%-29.55% 50.07B
+1.49%+3.89%+15.12%+53.65% 49.92B
-0.97%-3.06%+29.09%-2.26% 32.69B
+0.12%+9.67% - - 30.44B
-0.85%+2.24%+41.65%-1.32% 26.07B
-1.58%+7.22%+23.81%-6.14% 23.55B
Average +0.31%+1.13%+1.51%+0.61% 56B
Weighted average by Cap. +0.37%-0.01%-2.98%+13.36%

Financials

2026 *2027 *
Net sales 2.09M 1.83M 1.73M 1.58M 2.95M 200M 2.97M 20.68M 8.01M 102M 7.83M 7.66M 328M 8.94M 7.84M 7.41M 6.75M 12.63M 856M 12.72M 88.62M 34.32M 438M 33.55M 32.82M 1.41B
Net income -19.42M -17.04M -16.1M -14.67M -27.46M -1.86B -27.66M -193M -74.61M -951M -72.93M -71.35M -3.06B -22.87M -20.07M -18.95M -17.27M -32.33M -2.19B -32.56M -227M -87.83M -1.12B -85.85M -84M -3.6B
Net Debt - -
Logo Femasys Inc.
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Employees
53
Date Price Change Volume
26-09-25 US$2.480 +2.06% 36,164
26-09-24 US$2.430 -5.81% 103,669
26-09-23 US$2.580 +0.78% 34,129
26-09-22 US$2.560 +1.19% 73,289
26-09-21 US$2.530 -2.32% 32,391
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.480USD
Average target price
14.33USD
Spread / Average Target
+477.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FEMY Stock